Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,263
in 2 filings

Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-12-15 Nicholson John SVP & Chief Financial Officer Grant or award · Stock Option +22,000 22,000
2015-12-15 ROBIN HOWARD W President & CEO Grant or award · Restricted Stock Unit +67,500 67,500
2015-12-15 ROBIN HOWARD W President & CEO Grant or award · Stock Option +56,250 56,250
2015-12-15 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Restricted Stock Unit +15,000 15,000
2015-12-15 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +12,500 12,500
2015-12-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Restricted Stock Unit +10,500 10,500
2015-12-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +8,750 8,750
2015-12-15 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award · Restricted Stock Unit +18,750 18,750
2015-12-15 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award · Stock Option +22,500 22,500
2015-12-15 ROBIN HOWARD W President & CEO Grant or award · Restricted Stock Unit +56,250 56,250
2015-12-15 ROBIN HOWARD W President & CEO Grant or award · Stock Option +67,500 67,500
2015-12-15 Nicholson John SVP & Chief Financial Officer Grant or award · Restricted Stock Unit +22,000 22,000
2015-12-15 Nicholson John SVP & Chief Financial Officer Grant or award · Stock Option +26,000 26,000
2015-12-15 Labrucherie Gil M SVP & General Counsel Grant or award · Restricted Stock Unit +22,000 22,000
2015-12-15 Labrucherie Gil M SVP & General Counsel Grant or award · Stock Option +26,000 26,000
2015-12-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Restricted Stock Unit +22,000 22,000
2015-12-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +26,000 26,000
2015-12-15 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Restricted Stock Unit +12,500 12,500
2015-12-15 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +15,000 15,000
2015-12-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Restricted Stock Unit +8,750 8,750

Page 56 of 69 · 1,361 trades